Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 1/20 | 0.34 |
| ▸ | CDK4 | P11802 | 4/20 | 0.32 |
| ▸ | CCND1 | P24385 | 4/20 | 0.32 |
| ▸ | HTR7 | P34969 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 2/20 | 0.30 |
| ▸ | HTR2C | P28335 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL189124 | 0.80 | CDK4 (0.35) | CDK4CCND1HTR2AHTR2C | |
| SCHEMBL694594 | 0.77 | CDK4 (0.41) | GRM2CDK4CCND1HTR2AHTR2C | |
| SCHEMBL6228700 | 0.77 | CDK4 (0.35) | CDK4CCND1 | |
| SCHEMBL6229841 | 0.76 | HTR2C (0.41) | HTR2AHTR2C | |
| SCHEMBL6231638 | 0.76 | HTR2C (0.33) | CDK4CCND1HTR2AHTR2C | |
| SCHEMBL16719793 | 0.76 | HTR2A (0.40) | CDK4CCND1HTR2AHTR2C | |
| SCHEMBL698157 | 0.76 | HTR2C (0.40) | CDK4CCND1HTR2AHTR2C | |
| SCHEMBL5814894 | 0.75 | CDK4 (0.44) | CDK4CCND1HTR2AHTR2C | |
| SCHEMBL16719574 | 0.74 | — | — | |
| SCHEMBL418336 | 0.74 | CDK4 (0.61) | CDK4CCND1HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1595866-B1 | Cyanopyrrolidines useful for the treatment of inter alia metabolic syndrome | SANWA KAGAKU KENKYUSHO CO (JP) | 2016-06-08 | — | — | EP | disclosed |
| EP-1595866-A1 | COMPOUND INHIBITING DIPEPTIDYL PEPTIDASE IV | Sanwa Kagaku Kenkyusho Co., Ltd. (JP) | 2005-11-16 | — | — | EP | disclosed |